AACR Journal Editors Share Featured Articles
For the first Editors’ Picks collection of 2022, the editors of the AACR journals highlighted studies that assessed the...
Category: Journals
For the first Editors’ Picks collection of 2022, the editors of the AACR journals highlighted studies that assessed the...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
The new year brings a new chapter in the holy book of cancer biology with the publication in the...
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of...
The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal...
We’re closing out 2021 on the blog with Editors’ Picks, our monthly staple featuring articles handpicked by the editors of the AACR...
When the COVID-19 pandemic forced much of the world to shut down, and many days seemed bleak, it was...
Triple-negative breast cancer (TNBC) is aggressive, with high risk of metastasis and recurrence, and is challenging to treat due to a lack of effective targeted therapies. However, a higher...
Cancer is a very complex disease. Cancer cells often have the ability to rewire some of their functions to survive in harsh...
As you snack on turkey sandwiches and leftover pumpkin pie, check out the articles highlighted by the editors of...